Search results
'Premier AI Platform": Oppenheimer expects GPT-5 will be released by year end By Investing.com
Investing.com· 14 hours agoOppenheimer predicts OpenAI's GPT-5 release by year-end, solidifying their AI leadership. "We think...
Oppenheimer ups Addus HomeCare shares target on IL rate hike By Investing.com
Investing.com· 14 hours agoOn Friday, Oppenheimer adjusted its financial outlook for Addus HomeCare (NASDAQ:ADUS) shares, a...
Oppenheimer & Co. Inc. Sells 8,378 Shares of Truist Financial Co. (NYSE:TFC)
ETF DAILY NEWS· 16 hours agoOppenheimer & Co. Inc. trimmed its holdings in shares of Truist Financial Co. (NYSE:TFC – Free...
9 new to Prime Video movies with 90% or higher on Rotten Tomatoes
Tom's Guide via Yahoo News· 2 days agoThere’s plenty to shout about in this collection of highly-rated Prime Video movies, but the...
3 underrated movies on Hulu you need to watch in June 2024
Digital Trends via Yahoo News· 7 hours agoWith Lisa by their side, the boys’ popularity skyrockets, putting them on the radar of their...
Oppenheimer & Co. Inc. Purchases 1,597 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)
ETF DAILY NEWS· 16 hours agoOppenheimer & Co. Inc. increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 13.0% in the fourth quarter, according to its most recent ...
IFF's Focus On Health And Environment Set To Drive Stock Momentum, Says Analyst - Intl Flavors &...
Benzinga· 9 hours agoOppenheimer initiates coverage on IFF at Outperform rating with $116 price target. Analyst sees...
Best Buy and Microsoft score price-target hikes — plus, TJX plans to enter a new market
CNBC· 6 hours agoMSFT YTD mountain Microsoft (MSFT) year-to-date performance The news: Oppenheimer boosted...
Here are Friday's biggest analyst calls: Nio, Nvidia, UPS, Amazon, Oracle, Lyft, Microsoft, Walmart,...
CNBC· 14 hours agoHere are Friday's biggest calls on Wall Street: Oppenheimer initiates International Flavors as...
Kymera Therapeutics director sells over $280k in company stock By Investing.com
Investing.com· 3 hours agoKymera Therapeutics, Inc. (NASDAQ:KYMR) has reported a recent series of stock transactions by...